Global Organoids Market Growth (Status and Outlook) 2023-2029

Global Organoids Market Growth (Status and Outlook) 2023-2029

Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality.
LPI (LP Information)' newest research report, the “Organoids Industry Forecast” looks at past sales and reviews total world Organoids sales in 2022, providing a comprehensive analysis by region and market sector of projected Organoids sales for 2023 through 2029. With Organoids sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Organoids industry.
This Insight Report provides a comprehensive analysis of the global Organoids landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Organoids portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Organoids market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organoids and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organoids.
The global Organoids market size is projected to grow from US$ 86 million in 2022 to US$ 292.4 million in 2029; it is expected to grow at a CAGR of 19.1% from 2023 to 2029.
In China, the key players of organoids include Thermo Fisher Scientific, Merck, Corning, Lonza, Chuangxin International, etc. The top five players hold a share around 76% of China market. East China is the largest China market, has a share about 35%, followed by North China and South China, with share 22% and 17%, separately.
This report presents a comprehensive overview, market shares, and growth opportunities of Organoids market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Stem Cell Source
Tumor Cell Source
Segmentation by application
Biopharmaceutical Companies
Hospital
Academics and Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Tanwang Medical
Ketu Medicine
Chuangxin International

Please note: The report will take approximately 2 business days to prepare and deliver.